share_log

8-K: Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies

8-K: Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies

8-K:Kiora Pharmaceuticals公佈第二季度業績;視網膜疾病藥物研發渠道正在向兩項2期研究邁進
美股SEC公告 ·  08/09 19:07
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息